Sign up for free shipping on all website orders, no minimum required, and get exclusive coupons!
Maximum quantity allowed is 999
CAS RN: 39262-14-1 | Product Number: G0590
Ginsenoside C-K
Purity: >95.0%(HPLC)
- 20(S)-Ginsenoside Ck
- 3β,12β-Dihydroxydammar-24-en-20-yl β-D-Glucopyranoside
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
Shipping Information
|
|---|---|---|---|---|---|---|
| 50MG |
$118.00
|
Contact Us | Contact Us | ≥40 |
|
* Items in stock locally typically ship the same day of ordering. Items from Japan stock are able to ship from a US warehouse within 2 weeks after ordering. For additional estimated shipment times, please refer to the Shipping Simulation tool. Note: Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | G0590 |
Purity / Analysis Method
|
>95.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__3__6H__6__2O__8 = 622.88 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 39262-14-1 |
| Reaxys Registry Number | 5785005 |
| PubChem Substance ID | 468591952 |
| MDL Number | MFCD07772261 |
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Specific rotation | +37.0 to +41.0 deg(C=1,pyridine) |
| NMR | confirm to structure |
| Melting Point | 178 °C |
| RTECS# | LZ5776536 |
| HS Number | 2938.90.0000 |
References
- Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng
- Constitutive β-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria
- Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-The key step of inflammation
- A review of biotransformation and pharmacology of ginsenoside compound K
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.
